Charles River Laboratories | CRL - Selling And Administration Expenses



Charles River Laboratories reported $185.82M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Agilent USD 417M 37M Jul/2025
Align Technology USD 448.69M 1.06M Jun/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Bruker USD 231.4M 6M Jun/2025
Cardinal Health USD 1.48B 169M Jun/2025
Charles River Laboratories USD 185.82M 8.02M Jun/2025
Cigna USD 3.43B 564M Jun/2025
CVS Health USD 10.52B 22M Dec/2024
Danaher USD 2.36B 502M Jun/2025
Dentsply International USD 334M 23M Jun/2025
Elevance Health USD 10.24B 46M Jun/2025
Galapagos EUR 30.67M 13.12M Jun/2025
Hologic USD 251.3M 15.1M Jun/2025
Humana 3.36B 614M Mar/2025
Illumina USD 234M 13M Jun/2025
Incyte USD 331.02M 5.33M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Laboratory Of America USD 579.3M 33.3M Jun/2025
McKesson USD 2.2B 222M Jun/2025
Merck EUR 1.48B 9M Jun/2025
Mettler Toledo International USD 247.3M 4.5M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Quest Diagnostics USD 486M 10M Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Thermo Fisher Scientific USD 1.78B 58M Jun/2025
United Therapeutics USD 212.5M 42.4M Jun/2025
UnitedHealth USD 13.59B 1.1B Mar/2025
Waters USD 201.26M 26.38M Jun/2025
West Pharmaceutical Services USD 95.9M 7.9M Jun/2025